https://stock.noler.com/us/stock/medicines-co-de https://stock.noler.com/us/stock/medicines-co-de/accounts-payable https://stock.noler.com/us/stock/medicines-co-de/accounts-receivable https://stock.noler.com/us/stock/medicines-co-de/accrued-liabilities-current https://stock.noler.com/us/stock/medicines-co-de/accrued-marketing-costs-current https://stock.noler.com/us/stock/medicines-co-de/accrued-professional-fees-current https://stock.noler.com/us/stock/medicines-co-de/accrued-royalties-current https://stock.noler.com/us/stock/medicines-co-de/accumulated-amortization-deferred-finance-costs https://stock.noler.com/us/stock/medicines-co-de/accumulated-depreciation https://stock.noler.com/us/stock/medicines-co-de/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/medicines-co-de/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/medicines-co-de/acquisition-step-acquisition-equity-interest-in-acquiree-remeasurement-gain https://stock.noler.com/us/stock/medicines-co-de/acquisitions https://stock.noler.com/us/stock/medicines-co-de/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/medicines-co-de/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/medicines-co-de/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/medicines-co-de/advertising-expense https://stock.noler.com/us/stock/medicines-co-de/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/medicines-co-de/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/medicines-co-de/amended-reports-10-k https://stock.noler.com/us/stock/medicines-co-de/amended-reports-10-q https://stock.noler.com/us/stock/medicines-co-de/amortization https://stock.noler.com/us/stock/medicines-co-de/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/medicines-co-de/amortization-of-financing-costs https://stock.noler.com/us/stock/medicines-co-de/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/medicines-co-de/aoci https://stock.noler.com/us/stock/medicines-co-de/area-of-real-estate-property https://stock.noler.com/us/stock/medicines-co-de/asset-impairment-charges https://stock.noler.com/us/stock/medicines-co-de/assets-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/medicines-co-de/available-for-sale-accumulated-gross-unrealized-gain-loss-before-tax https://stock.noler.com/us/stock/medicines-co-de/available-for-sale-amortized-cost https://stock.noler.com/us/stock/medicines-co-de/available-for-sale-current https://stock.noler.com/us/stock/medicines-co-de/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/medicines-co-de/available-for-sale-debt-current https://stock.noler.com/us/stock/medicines-co-de/available-for-sale-debt-securities https://stock.noler.com/us/stock/medicines-co-de/available-for-sale-fair-value-disclosure https://stock.noler.com/us/stock/medicines-co-de/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/medicines-co-de/available-for-sale-gross-unrealized-gain https://stock.noler.com/us/stock/medicines-co-de/available-for-sale-gross-unrealized-gains https://stock.noler.com/us/stock/medicines-co-de/available-for-sale-noncurrent https://stock.noler.com/us/stock/medicines-co-de/available-for-sale-securities https://stock.noler.com/us/stock/medicines-co-de/basic-shares https://stock.noler.com/us/stock/medicines-co-de/business-acquisition-cost-of-acquired-entity-cash-paid https://stock.noler.com/us/stock/medicines-co-de/business-acquisition-pro-forma-earnings-per-share-basic https://stock.noler.com/us/stock/medicines-co-de/business-acquisition-pro-forma-earnings-per-share-diluted https://stock.noler.com/us/stock/medicines-co-de/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/medicines-co-de/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/medicines-co-de/business-exit-costs https://stock.noler.com/us/stock/medicines-co-de/business-exit-costs-1 https://stock.noler.com/us/stock/medicines-co-de/buyback-authorization https://stock.noler.com/us/stock/medicines-co-de/buybacks-payments-for-hedge-financing-activities https://stock.noler.com/us/stock/medicines-co-de/buybacks-payments-for-repurchase-of-warrants https://stock.noler.com/us/stock/medicines-co-de/buybacks-share-repurchases https://stock.noler.com/us/stock/medicines-co-de/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/medicines-co-de/buybacks-treasury-shares-acquired https://stock.noler.com/us/stock/medicines-co-de/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/medicines-co-de/capital-expenditures https://stock.noler.com/us/stock/medicines-co-de/cash https://stock.noler.com/us/stock/medicines-co-de/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/medicines-co-de/cash-and-equivalents https://stock.noler.com/us/stock/medicines-co-de/cash-and-restricted-cash https://stock.noler.com/us/stock/medicines-co-de/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/medicines-co-de/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/medicines-co-de/cash-flow-breakdown https://stock.noler.com/us/stock/medicines-co-de/clinical-trials https://stock.noler.com/us/stock/medicines-co-de/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/medicines-co-de/common-stock-value https://stock.noler.com/us/stock/medicines-co-de/comprehensive-income https://stock.noler.com/us/stock/medicines-co-de/comprehensive-income-net-of-tax-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/medicines-co-de/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/medicines-co-de/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/medicines-co-de/contract-with-customer-refund-liability https://stock.noler.com/us/stock/medicines-co-de/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/medicines-co-de/convertible-debt-current https://stock.noler.com/us/stock/medicines-co-de/cost-method-investments https://stock.noler.com/us/stock/medicines-co-de/cost-method-investments-realized-gain-loss https://stock.noler.com/us/stock/medicines-co-de/cost-of-revenue https://stock.noler.com/us/stock/medicines-co-de/costmethod-investments-other-than-temporary-impairment https://stock.noler.com/us/stock/medicines-co-de/costs-and-expenses https://stock.noler.com/us/stock/medicines-co-de/cover-page-shares-outstanding https://stock.noler.com/us/stock/medicines-co-de/cumulative-effect-of-new-accounting-principle-in-period-of-adoption https://stock.noler.com/us/stock/medicines-co-de/current-assets https://stock.noler.com/us/stock/medicines-co-de/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/medicines-co-de/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/medicines-co-de/current-income-tax-expense-benefit https://stock.noler.com/us/stock/medicines-co-de/current-liabilities https://stock.noler.com/us/stock/medicines-co-de/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/medicines-co-de/debt-carrying-amount https://stock.noler.com/us/stock/medicines-co-de/debt-convertible-conversion-price https://stock.noler.com/us/stock/medicines-co-de/debt-convertible-conversion-ratio https://stock.noler.com/us/stock/medicines-co-de/debt-convertible-conversion-ratio-1 https://stock.noler.com/us/stock/medicines-co-de/debt-convertible-effective-interest-rate https://stock.noler.com/us/stock/medicines-co-de/debt-convertible-threshold-trading-days https://stock.noler.com/us/stock/medicines-co-de/debt-face-amount https://stock.noler.com/us/stock/medicines-co-de/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/medicines-co-de/debt-repaid https://stock.noler.com/us/stock/medicines-co-de/debt-unamortized-discount https://stock.noler.com/us/stock/medicines-co-de/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/medicines-co-de/deferred-finance-costs-net https://stock.noler.com/us/stock/medicines-co-de/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/medicines-co-de/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/medicines-co-de/deferred-income-tax-liabilities https://stock.noler.com/us/stock/medicines-co-de/deferred-revenue https://stock.noler.com/us/stock/medicines-co-de/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/medicines-co-de/deferred-tax-assets-gross https://stock.noler.com/us/stock/medicines-co-de/deferred-tax-assets-hedging-transactions https://stock.noler.com/us/stock/medicines-co-de/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/medicines-co-de/deferred-tax-assets-liabilities-net-current https://stock.noler.com/us/stock/medicines-co-de/deferred-tax-assets-liabilities-net-noncurrent https://stock.noler.com/us/stock/medicines-co-de/deferred-tax-assets-net https://stock.noler.com/us/stock/medicines-co-de/deferred-tax-assets-net-current https://stock.noler.com/us/stock/medicines-co-de/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/medicines-co-de/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/medicines-co-de/deferred-tax-assets-other https://stock.noler.com/us/stock/medicines-co-de/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/medicines-co-de/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/medicines-co-de/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/medicines-co-de/deferred-tax-assets-valuation-allowance-current https://stock.noler.com/us/stock/medicines-co-de/deferred-tax-liabilities https://stock.noler.com/us/stock/medicines-co-de/deferred-tax-liabilities-financing-arrangements https://stock.noler.com/us/stock/medicines-co-de/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/medicines-co-de/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/medicines-co-de/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/medicines-co-de/defined-benefit-plan-contributions-by-employer https://stock.noler.com/us/stock/medicines-co-de/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/medicines-co-de/defined-contribution-plan-maximum-annual-contribution-per-employee-percent https://stock.noler.com/us/stock/medicines-co-de/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/medicines-co-de/depreciation https://stock.noler.com/us/stock/medicines-co-de/depreciation-and-amortization https://stock.noler.com/us/stock/medicines-co-de/depreciation-and-amortization-expense https://stock.noler.com/us/stock/medicines-co-de/derivative-notional-amount https://stock.noler.com/us/stock/medicines-co-de/diluted-shares https://stock.noler.com/us/stock/medicines-co-de/dilutive-shares https://stock.noler.com/us/stock/medicines-co-de/discontinued-operation-gain-loss-from-disposal-of-discontinued-operation-before-income-tax https://stock.noler.com/us/stock/medicines-co-de/discontinued-operation-income-loss-from-discontinued-operation-net-of-tax-per-basic-share https://stock.noler.com/us/stock/medicines-co-de/discontinued-operation-income-loss-from-discontinued-operation-net-of-tax-per-diluted-share https://stock.noler.com/us/stock/medicines-co-de/disposal-group-including-discontinued-operation-assets-noncurrent https://stock.noler.com/us/stock/medicines-co-de/disposal-group-including-discontinued-operation-goodwill-noncurrent https://stock.noler.com/us/stock/medicines-co-de/disposal-group-not-discontinued-operation-gain-loss-on-disposal https://stock.noler.com/us/stock/medicines-co-de/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/medicines-co-de/effective-tax-rate https://stock.noler.com/us/stock/medicines-co-de/employee-related-liabilities-current https://stock.noler.com/us/stock/medicines-co-de/eps https://stock.noler.com/us/stock/medicines-co-de/eps-basic https://stock.noler.com/us/stock/medicines-co-de/equity-method-investment-other-than-temporary-impairment https://stock.noler.com/us/stock/medicines-co-de/escrow-deposit https://stock.noler.com/us/stock/medicines-co-de/excess-tax-benefit-from-share-based-compensation-financing-activities https://stock.noler.com/us/stock/medicines-co-de/excess-tax-benefit-from-share-based-compensation-operating-activities https://stock.noler.com/us/stock/medicines-co-de/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/medicines-co-de/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/medicines-co-de/fair-value-concentration-of-risk-cash-and-cash-equivalents https://stock.noler.com/us/stock/medicines-co-de/fair-value-hedges-at-fair-value-net https://stock.noler.com/us/stock/medicines-co-de/fair-value-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/medicines-co-de/fair-value-liabilities-change-in-unrealized-gain-loss-included-in-other-income https://stock.noler.com/us/stock/medicines-co-de/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/medicines-co-de/fair-value-of-assets-acquired https://stock.noler.com/us/stock/medicines-co-de/financing-cash-flow https://stock.noler.com/us/stock/medicines-co-de/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/medicines-co-de/finite-lived-intangible-assets-amortization-expense https://stock.noler.com/us/stock/medicines-co-de/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/medicines-co-de/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/medicines-co-de/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/medicines-co-de/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/medicines-co-de/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/medicines-co-de/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/medicines-co-de/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/medicines-co-de/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/medicines-co-de/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/medicines-co-de/finite-lived-intangible-assets-weighted-average-useful-life https://stock.noler.com/us/stock/medicines-co-de/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/medicines-co-de/foreign-earnings https://stock.noler.com/us/stock/medicines-co-de/foreign-pretax-income https://stock.noler.com/us/stock/medicines-co-de/future-amortization-expense-after-year-five https://stock.noler.com/us/stock/medicines-co-de/future-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/medicines-co-de/future-amortization-expense-year-five https://stock.noler.com/us/stock/medicines-co-de/future-amortization-expense-year-four https://stock.noler.com/us/stock/medicines-co-de/future-amortization-expense-year-one https://stock.noler.com/us/stock/medicines-co-de/future-amortization-expense-year-three https://stock.noler.com/us/stock/medicines-co-de/future-amortization-expense-year-two https://stock.noler.com/us/stock/medicines-co-de/gain-loss-on-investments https://stock.noler.com/us/stock/medicines-co-de/gain-loss-on-sale-of-business https://stock.noler.com/us/stock/medicines-co-de/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/medicines-co-de/gain-loss-related-to-litigation-settlement https://stock.noler.com/us/stock/medicines-co-de/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/medicines-co-de/geographic-revenue-from-external-customers-attributed-to-foreign-countries https://stock.noler.com/us/stock/medicines-co-de/goodwill https://stock.noler.com/us/stock/medicines-co-de/goodwill-acquired https://stock.noler.com/us/stock/medicines-co-de/goodwill-allocation-adjustment https://stock.noler.com/us/stock/medicines-co-de/goodwill-change https://stock.noler.com/us/stock/medicines-co-de/goodwill-foreign-currency-translation-gain-loss https://stock.noler.com/us/stock/medicines-co-de/goodwill-impairment-loss https://stock.noler.com/us/stock/medicines-co-de/goodwill-purchase-accounting-adjustments https://stock.noler.com/us/stock/medicines-co-de/goodwill-translation-adjustments https://stock.noler.com/us/stock/medicines-co-de/goodwill-written-off-related-to-sale-of-business-unit https://stock.noler.com/us/stock/medicines-co-de/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/medicines-co-de/impairment-of-investments https://stock.noler.com/us/stock/medicines-co-de/impairment-of-long-lived-assets-to-be-disposed-of https://stock.noler.com/us/stock/medicines-co-de/income-loss-from https://stock.noler.com/us/stock/medicines-co-de/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/medicines-co-de/income-loss-from-discontinued-operations-net-of-tax-attributable-to-reporting-entity https://stock.noler.com/us/stock/medicines-co-de/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/medicines-co-de/income-loss-from-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/medicines-co-de/income-loss-from-per-basic-share https://stock.noler.com/us/stock/medicines-co-de/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/medicines-co-de/income-tax https://stock.noler.com/us/stock/medicines-co-de/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/medicines-co-de/income-tax-expense-benefit https://stock.noler.com/us/stock/medicines-co-de/income-taxes-paid https://stock.noler.com/us/stock/medicines-co-de/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/medicines-co-de/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/medicines-co-de/increase-decrease-in-accrued-interest-receivable-net https://stock.noler.com/us/stock/medicines-co-de/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/medicines-co-de/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/medicines-co-de/increase-decrease-in-inventories https://stock.noler.com/us/stock/medicines-co-de/increase-decrease-in-other-current-liabilities https://stock.noler.com/us/stock/medicines-co-de/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/medicines-co-de/increase-decrease-in-other-operating-capital-net https://stock.noler.com/us/stock/medicines-co-de/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/medicines-co-de/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/medicines-co-de/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/medicines-co-de/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/medicines-co-de/incremental-common-shares-attributable-to-conversion-of-debt-securities https://stock.noler.com/us/stock/medicines-co-de/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/medicines-co-de/indefinite-lived-intangible-assets https://stock.noler.com/us/stock/medicines-co-de/indefinite-lived-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/medicines-co-de/insider-transactions-corporate-securities https://stock.noler.com/us/stock/medicines-co-de/insider-transactions-corporate-securities/purchases https://stock.noler.com/us/stock/medicines-co-de/insider-transactions-other https://stock.noler.com/us/stock/medicines-co-de/insider-transactions-stock-options https://stock.noler.com/us/stock/medicines-co-de/insider-transactions-stock-options/purchases https://stock.noler.com/us/stock/medicines-co-de/insider-transactions-swaps-forwards-futures https://stock.noler.com/us/stock/medicines-co-de/intangible-assets-gross-excluding-goodwill https://stock.noler.com/us/stock/medicines-co-de/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/medicines-co-de/interest-expense https://stock.noler.com/us/stock/medicines-co-de/interest-expense-debt-excluding-amortization https://stock.noler.com/us/stock/medicines-co-de/interest-expense-on-debt https://stock.noler.com/us/stock/medicines-co-de/interest-paid https://stock.noler.com/us/stock/medicines-co-de/interest-paid-net https://stock.noler.com/us/stock/medicines-co-de/interest-payable-current https://stock.noler.com/us/stock/medicines-co-de/interest-receivable-current https://stock.noler.com/us/stock/medicines-co-de/inventory https://stock.noler.com/us/stock/medicines-co-de/inventory-finished-goods https://stock.noler.com/us/stock/medicines-co-de/inventory-raw-materials https://stock.noler.com/us/stock/medicines-co-de/inventory-work-in-process https://stock.noler.com/us/stock/medicines-co-de/inventory-write-down https://stock.noler.com/us/stock/medicines-co-de/investing-cash-flow https://stock.noler.com/us/stock/medicines-co-de/investment-income-net-amortization-of-discount-and-premium https://stock.noler.com/us/stock/medicines-co-de/lease-and-rental-expense https://stock.noler.com/us/stock/medicines-co-de/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/medicines-co-de/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/medicines-co-de/level-3-asset-gain-loss-included-in-earnings https://stock.noler.com/us/stock/medicines-co-de/level-3-asset-value https://stock.noler.com/us/stock/medicines-co-de/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/medicines-co-de/liabilities-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/medicines-co-de/liabilities-of-disposal-group-including-discontinued-operation-noncurrent https://stock.noler.com/us/stock/medicines-co-de/long-term-debt-fair-value https://stock.noler.com/us/stock/medicines-co-de/minority-interest https://stock.noler.com/us/stock/medicines-co-de/minority-interest-decrease-from-redemptions https://stock.noler.com/us/stock/medicines-co-de/minority-interest-ownership-percentage-by-noncontrolling-owners https://stock.noler.com/us/stock/medicines-co-de/money-market-funds-at-carrying-value https://stock.noler.com/us/stock/medicines-co-de/net-change-in-cash https://stock.noler.com/us/stock/medicines-co-de/net-income https://stock.noler.com/us/stock/medicines-co-de/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/medicines-co-de/noncurrent-assets https://stock.noler.com/us/stock/medicines-co-de/number-of-operating-segments https://stock.noler.com/us/stock/medicines-co-de/number-of-reporting-units https://stock.noler.com/us/stock/medicines-co-de/oci-before-reclassifications-net-of-tax https://stock.noler.com/us/stock/medicines-co-de/oci-before-reclassifications-net-of-tax-attributable-to-parent https://stock.noler.com/us/stock/medicines-co-de/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/medicines-co-de/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/medicines-co-de/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/medicines-co-de/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/medicines-co-de/oci-foreign-currency-transaction-and-translation-reclassification-adjustment-from-aoci-realized-upon-sale-or-liquidation-net-of-tax https://stock.noler.com/us/stock/medicines-co-de/oci-net-of-tax https://stock.noler.com/us/stock/medicines-co-de/oci-net-of-tax-2 https://stock.noler.com/us/stock/medicines-co-de/oci-net-of-tax-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/medicines-co-de/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/medicines-co-de/oci-unrealized-holding-gain-loss-on-securities-arising-tax https://stock.noler.com/us/stock/medicines-co-de/operating-cash-flow https://stock.noler.com/us/stock/medicines-co-de/operating-income https://stock.noler.com/us/stock/medicines-co-de/operating-lease-assets https://stock.noler.com/us/stock/medicines-co-de/operating-lease-cost https://stock.noler.com/us/stock/medicines-co-de/operating-lease-liability https://stock.noler.com/us/stock/medicines-co-de/operating-lease-liability-current https://stock.noler.com/us/stock/medicines-co-de/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/medicines-co-de/operating-lease-payments https://stock.noler.com/us/stock/medicines-co-de/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/medicines-co-de/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/medicines-co-de/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/medicines-co-de/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/medicines-co-de/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/medicines-co-de/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/medicines-co-de/operating-loss-carryforwards https://stock.noler.com/us/stock/medicines-co-de/other-assets https://stock.noler.com/us/stock/medicines-co-de/other-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/medicines-co-de/other-current-liabilities https://stock.noler.com/us/stock/medicines-co-de/other-noncurrent-assets https://stock.noler.com/us/stock/medicines-co-de/other-noncurrent-liabilities https://stock.noler.com/us/stock/medicines-co-de/other-nonoperating-income https://stock.noler.com/us/stock/medicines-co-de/other-nonoperating-income-expense https://stock.noler.com/us/stock/medicines-co-de/other-payments-to-acquire-businesses https://stock.noler.com/us/stock/medicines-co-de/other-restructuring-costs https://stock.noler.com/us/stock/medicines-co-de/other-tax-expense-benefit https://stock.noler.com/us/stock/medicines-co-de/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/medicines-co-de/paid-in-capital-equity-component-of-convertible-debt https://stock.noler.com/us/stock/medicines-co-de/paid-in-capital-equity-component-of-convertible-debt-subsequent-adjustments https://stock.noler.com/us/stock/medicines-co-de/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/medicines-co-de/paid-in-capital-tax-effect-from-share-based-compensation https://stock.noler.com/us/stock/medicines-co-de/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/medicines-co-de/patents-active https://stock.noler.com/us/stock/medicines-co-de/patents-pending https://stock.noler.com/us/stock/medicines-co-de/patents-rejected https://stock.noler.com/us/stock/medicines-co-de/payment-for-contingent-consideration-liability-financing-activities https://stock.noler.com/us/stock/medicines-co-de/payment-for-contingent-consideration-liability-operating-activities https://stock.noler.com/us/stock/medicines-co-de/payments-for-derivative-instrument-financing-activities https://stock.noler.com/us/stock/medicines-co-de/payments-for-legal-settlements https://stock.noler.com/us/stock/medicines-co-de/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/medicines-co-de/payments-for-restructuring https://stock.noler.com/us/stock/medicines-co-de/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/medicines-co-de/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/medicines-co-de/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/medicines-co-de/payments-to-acquire-equity-method-investments https://stock.noler.com/us/stock/medicines-co-de/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/medicines-co-de/payments-to-acquire-interest-in-subsidiaries-and-affiliates https://stock.noler.com/us/stock/medicines-co-de/payments-to-minority-shareholders https://stock.noler.com/us/stock/medicines-co-de/preferred-shares-facts https://stock.noler.com/us/stock/medicines-co-de/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/medicines-co-de/preferred-stock-shares-authorized https://stock.noler.com/us/stock/medicines-co-de/preferred-stock-shares-issued https://stock.noler.com/us/stock/medicines-co-de/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/medicines-co-de/preferred-stock-value https://stock.noler.com/us/stock/medicines-co-de/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/medicines-co-de/pretax-income https://stock.noler.com/us/stock/medicines-co-de/pretax-income-domestic https://stock.noler.com/us/stock/medicines-co-de/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/medicines-co-de/proceeds-from-convertible-debt https://stock.noler.com/us/stock/medicines-co-de/proceeds-from-derivative-instrument-financing-activities https://stock.noler.com/us/stock/medicines-co-de/proceeds-from-divestiture-of-businesses https://stock.noler.com/us/stock/medicines-co-de/proceeds-from-hedge-financing-activities https://stock.noler.com/us/stock/medicines-co-de/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/medicines-co-de/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/medicines-co-de/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/medicines-co-de/proceeds-from-sale-and-maturity-of-available-for-sale-securities https://stock.noler.com/us/stock/medicines-co-de/proceeds-from-sale-and-maturity-of-other-investments https://stock.noler.com/us/stock/medicines-co-de/proceeds-from-sale-of-productive-assets https://stock.noler.com/us/stock/medicines-co-de/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/medicines-co-de/proceeds-from-stock-issued https://stock.noler.com/us/stock/medicines-co-de/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/medicines-co-de/profit-loss https://stock.noler.com/us/stock/medicines-co-de/property-plant-and-equipment-gross https://stock.noler.com/us/stock/medicines-co-de/property-plant-equipment https://stock.noler.com/us/stock/medicines-co-de/public-float https://stock.noler.com/us/stock/medicines-co-de/reclassification-from-accumulated-oci-current-period-net-of-tax https://stock.noler.com/us/stock/medicines-co-de/reclassification-from-aoci-current-period-net-of-tax-attributable-to-parent https://stock.noler.com/us/stock/medicines-co-de/reclassifications-of-temporary-to-permanent-equity https://stock.noler.com/us/stock/medicines-co-de/recorded-unconditional-purchase-obligation https://stock.noler.com/us/stock/medicines-co-de/recorded-unconditional-purchase-obligation-due-after-fifth-year https://stock.noler.com/us/stock/medicines-co-de/recorded-unconditional-purchase-obligation-due-in-fifth-year https://stock.noler.com/us/stock/medicines-co-de/recorded-unconditional-purchase-obligation-due-in-fourth-year https://stock.noler.com/us/stock/medicines-co-de/recorded-unconditional-purchase-obligation-due-in-second-year https://stock.noler.com/us/stock/medicines-co-de/recorded-unconditional-purchase-obligation-due-in-third-year https://stock.noler.com/us/stock/medicines-co-de/recorded-unconditional-purchase-obligation-due-within-one-year https://stock.noler.com/us/stock/medicines-co-de/reimbursement-revenue https://stock.noler.com/us/stock/medicines-co-de/research-and-development https://stock.noler.com/us/stock/medicines-co-de/research-and-development-in-process https://stock.noler.com/us/stock/medicines-co-de/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/medicines-co-de/restructuring-and-related-cost-expected-cost-remaining https://stock.noler.com/us/stock/medicines-co-de/restructuring-and-related-cost-number-of-positions-eliminated https://stock.noler.com/us/stock/medicines-co-de/restructuring-charges https://stock.noler.com/us/stock/medicines-co-de/restructuring-costs https://stock.noler.com/us/stock/medicines-co-de/restructuring-reserve https://stock.noler.com/us/stock/medicines-co-de/restructuring-reserve-accrual-adjustment https://stock.noler.com/us/stock/medicines-co-de/restructuring-reserve-accrual-adjustment-1 https://stock.noler.com/us/stock/medicines-co-de/restructuring-reserve-period-expense https://stock.noler.com/us/stock/medicines-co-de/restructuring-reserve-settled-with-cash https://stock.noler.com/us/stock/medicines-co-de/restructuring-reserve-settled-without-cash https://stock.noler.com/us/stock/medicines-co-de/restructuring-reserve-settled-without-cash-1 https://stock.noler.com/us/stock/medicines-co-de/restructuring-reserve-settled-without-cash-2 https://stock.noler.com/us/stock/medicines-co-de/retained-earnings https://stock.noler.com/us/stock/medicines-co-de/revenue https://stock.noler.com/us/stock/medicines-co-de/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/medicines-co-de/revenue-recognition-sales-returns-reserve-for-sales-returns https://stock.noler.com/us/stock/medicines-co-de/royalty-revenue https://stock.noler.com/us/stock/medicines-co-de/sale-of-stock-price-per-share https://stock.noler.com/us/stock/medicines-co-de/sales-revenue-goods-net https://stock.noler.com/us/stock/medicines-co-de/sales-revenue-net https://stock.noler.com/us/stock/medicines-co-de/sec-comment-letters-corresp https://stock.noler.com/us/stock/medicines-co-de/sec-comment-letters-upload https://stock.noler.com/us/stock/medicines-co-de/sec-filings-10-k https://stock.noler.com/us/stock/medicines-co-de/sec-filings-10-k405 https://stock.noler.com/us/stock/medicines-co-de/sec-filings-10-q https://stock.noler.com/us/stock/medicines-co-de/sec-filings-15-12g https://stock.noler.com/us/stock/medicines-co-de/sec-filings-25-nse https://stock.noler.com/us/stock/medicines-co-de/sec-filings-8-a12g https://stock.noler.com/us/stock/medicines-co-de/sec-filings-8-k https://stock.noler.com/us/stock/medicines-co-de/sec-filings-ars https://stock.noler.com/us/stock/medicines-co-de/sec-filings-ct-order https://stock.noler.com/us/stock/medicines-co-de/sec-filings-def-14a https://stock.noler.com/us/stock/medicines-co-de/sec-filings-defa14a https://stock.noler.com/us/stock/medicines-co-de/sec-filings-defr14a https://stock.noler.com/us/stock/medicines-co-de/sec-filings-pre-14a https://stock.noler.com/us/stock/medicines-co-de/sec-filings-sc-14d9 https://stock.noler.com/us/stock/medicines-co-de/sec-filings-sc-to-c https://stock.noler.com/us/stock/medicines-co-de/sec-filings-sc-to-t https://stock.noler.com/us/stock/medicines-co-de/sec-filings-sd https://stock.noler.com/us/stock/medicines-co-de/secondary-offerings-form-424b2 https://stock.noler.com/us/stock/medicines-co-de/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/medicines-co-de/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/medicines-co-de/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/medicines-co-de/secondary-offerings-form-effect https://stock.noler.com/us/stock/medicines-co-de/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/medicines-co-de/secondary-offerings-form-posasr https://stock.noler.com/us/stock/medicines-co-de/secondary-offerings-form-rw https://stock.noler.com/us/stock/medicines-co-de/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/medicines-co-de/secondary-offerings-form-s-1mef https://stock.noler.com/us/stock/medicines-co-de/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/medicines-co-de/secondary-offerings-form-s-3asr https://stock.noler.com/us/stock/medicines-co-de/secondary-offerings-form-s-3mef https://stock.noler.com/us/stock/medicines-co-de/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/medicines-co-de/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/medicines-co-de/senior-notes https://stock.noler.com/us/stock/medicines-co-de/severance-costs https://stock.noler.com/us/stock/medicines-co-de/sga-expense https://stock.noler.com/us/stock/medicines-co-de/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-remaining-term https://stock.noler.com/us/stock/medicines-co-de/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/medicines-co-de/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/medicines-co-de/shareholders-equity https://stock.noler.com/us/stock/medicines-co-de/shares-authorized https://stock.noler.com/us/stock/medicines-co-de/shares-issued https://stock.noler.com/us/stock/medicines-co-de/shares-issued-shares-new-issues https://stock.noler.com/us/stock/medicines-co-de/short-term-investments https://stock.noler.com/us/stock/medicines-co-de/square-footage-of-real-estate-property https://stock.noler.com/us/stock/medicines-co-de/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/medicines-co-de/stock-award-fair-value-assumptions-expected-term https://stock.noler.com/us/stock/medicines-co-de/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/medicines-co-de/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/medicines-co-de/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/medicines-co-de/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/medicines-co-de/stock-award-rsu-forfeited-in-period-grant-date-fair-value https://stock.noler.com/us/stock/medicines-co-de/stock-award-rsu-forfeitures-grant-date-fair-value https://stock.noler.com/us/stock/medicines-co-de/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/medicines-co-de/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/medicines-co-de/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/medicines-co-de/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/medicines-co-de/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/medicines-co-de/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/medicines-co-de/stock-based-compensation https://stock.noler.com/us/stock/medicines-co-de/stock-compensation-cash-received-from-exercise-of-stock-options https://stock.noler.com/us/stock/medicines-co-de/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/medicines-co-de/stock-compensation-unrecognized-cost-recognition-period https://stock.noler.com/us/stock/medicines-co-de/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/medicines-co-de/stock-issued-new-shares-sold https://stock.noler.com/us/stock/medicines-co-de/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/medicines-co-de/stock-issued-shares-issued-shares-espps https://stock.noler.com/us/stock/medicines-co-de/stock-issued-shares-issued-shares-restricted-stock-award-gross https://stock.noler.com/us/stock/medicines-co-de/stock-issued-shares-issued-shares-share-based-compensation-gross https://stock.noler.com/us/stock/medicines-co-de/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/medicines-co-de/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/medicines-co-de/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/medicines-co-de/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/medicines-co-de/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/medicines-co-de/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/medicines-co-de/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/medicines-co-de/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/medicines-co-de/stock-repurchase-program-authorized-amount https://stock.noler.com/us/stock/medicines-co-de/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/medicines-co-de/sublease-income https://stock.noler.com/us/stock/medicines-co-de/tax-benefit-from-stock-options-exercised https://stock.noler.com/us/stock/medicines-co-de/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/medicines-co-de/tax-rate-reconciliation-share-based-compensation-excess-tax-benefit-amount https://stock.noler.com/us/stock/medicines-co-de/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/medicines-co-de/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/medicines-co-de/tax-reconciliation-disposition-of-business https://stock.noler.com/us/stock/medicines-co-de/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/medicines-co-de/tax-reconciliation-nondeductible-expense-impairment-losses https://stock.noler.com/us/stock/medicines-co-de/tax-reconciliation-nondeductible-expense-meals-and-entertainment https://stock.noler.com/us/stock/medicines-co-de/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/medicines-co-de/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/medicines-co-de/tax-reconciliation-tax-credits https://stock.noler.com/us/stock/medicines-co-de/tax-reconciliation-tax-exempt-income https://stock.noler.com/us/stock/medicines-co-de/temporary-equity-carrying-amount-including-portion-attributable-to-noncontrolling-interests https://stock.noler.com/us/stock/medicines-co-de/total-assets https://stock.noler.com/us/stock/medicines-co-de/total-liabilities https://stock.noler.com/us/stock/medicines-co-de/total-liabilities-and-equity https://stock.noler.com/us/stock/medicines-co-de/treasury-stock-number-of-shares-held https://stock.noler.com/us/stock/medicines-co-de/treasury-stock-shares https://stock.noler.com/us/stock/medicines-co-de/treasury-stock-value https://stock.noler.com/us/stock/medicines-co-de/unrecognized-tax-benefits https://stock.noler.com/us/stock/medicines-co-de/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/medicines-co-de/utb-decrease-from-settlements https://stock.noler.com/us/stock/medicines-co-de/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/medicines-co-de/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/medicines-co-de/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/medicines-co-de/valuation-allowance-amount https://stock.noler.com/us/stock/medicines-co-de/valuation-allowance-deferred-tax-asset-change-in-amount